JP2008530108A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008530108A5 JP2008530108A5 JP2007555228A JP2007555228A JP2008530108A5 JP 2008530108 A5 JP2008530108 A5 JP 2008530108A5 JP 2007555228 A JP2007555228 A JP 2007555228A JP 2007555228 A JP2007555228 A JP 2007555228A JP 2008530108 A5 JP2008530108 A5 JP 2008530108A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- medicament
- predisposed
- mammal
- manufacture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010028980 Neoplasm Diseases 0.000 claims 6
- 201000011510 cancer Diseases 0.000 claims 6
- 241000124008 Mammalia Species 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 241000725303 Human immunodeficiency virus Species 0.000 claims 2
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 2
- 239000002246 antineoplastic agent Substances 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 206010025323 Lymphomas Diseases 0.000 claims 1
- 208000034578 Multiple myelomas Diseases 0.000 claims 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims 1
- 208000001132 Osteoporosis Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 206010052779 Transplant rejections Diseases 0.000 claims 1
- 230000000259 anti-tumor effect Effects 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 claims 1
- 208000032839 leukemia Diseases 0.000 claims 1
- 210000004185 liver Anatomy 0.000 claims 1
- 210000004072 lung Anatomy 0.000 claims 1
- 201000000050 myeloid neoplasm Diseases 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 210000001672 ovary Anatomy 0.000 claims 1
- 210000000496 pancreas Anatomy 0.000 claims 1
- 210000002307 prostate Anatomy 0.000 claims 1
- 230000017854 proteolysis Effects 0.000 claims 1
- 230000002797 proteolythic effect Effects 0.000 claims 1
- 238000001959 radiotherapy Methods 0.000 claims 1
- 208000037803 restenosis Diseases 0.000 claims 1
- 210000002460 smooth muscle Anatomy 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65237005P | 2005-02-11 | 2005-02-11 | |
| US11/351,193 US7468383B2 (en) | 2005-02-11 | 2006-02-09 | Proteasome inhibitors and methods of using the same |
| PCT/US2006/004664 WO2006086600A1 (en) | 2005-02-11 | 2006-02-10 | Proteasome inhibitors and methods of using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008530108A JP2008530108A (ja) | 2008-08-07 |
| JP2008530108A5 true JP2008530108A5 (cg-RX-API-DMAC7.html) | 2009-04-02 |
Family
ID=36579482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007555228A Pending JP2008530108A (ja) | 2005-02-11 | 2006-02-10 | プロテアソーム阻害剤及びそれらを使用する方法 |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US7468383B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1846424B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2008530108A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE456571T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006213814B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2597273C (cg-RX-API-DMAC7.html) |
| CY (1) | CY1109985T1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE602006012013D1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1846424T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2339698T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL184678A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2007009664A (cg-RX-API-DMAC7.html) |
| MY (1) | MY147921A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ560607A (cg-RX-API-DMAC7.html) |
| PL (1) | PL1846424T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1846424E (cg-RX-API-DMAC7.html) |
| SI (1) | SI1846424T1 (cg-RX-API-DMAC7.html) |
| TW (1) | TWI367886B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006086600A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008011131A2 (en) * | 2006-07-21 | 2008-01-24 | Takeda Pharmaceutical Company Limited | Amide compounds |
| WO2007011760A2 (en) * | 2005-07-15 | 2007-01-25 | Kalypsys, Inc. | Inhibitors of mitotic kinesin |
| EP2623113B1 (en) | 2005-11-09 | 2017-05-31 | Onyx Therapeutics, Inc. | Compound for enzyme inhibition |
| NZ597545A (en) | 2006-06-19 | 2013-07-26 | Proteolix Inc | Peptide epoxyketones for proteasome inhibition |
| CN105837608B (zh) * | 2007-08-06 | 2018-06-08 | 米伦纽姆医药公司 | 蛋白酶体抑制剂及其组合物和用途 |
| US20110118274A1 (en) * | 2007-08-23 | 2011-05-19 | Cornell Research Foundation, Inc. | Proteasome inhibitors and their use in treating pathogen infection and cancer |
| CA2701778C (en) | 2007-10-04 | 2018-09-11 | Onyx Therapeutics, Inc. | Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides |
| EP2212334B1 (en) * | 2007-10-16 | 2012-08-15 | Millennium Pharmaceuticals, Inc. | Proteasome inhibitors |
| EP2088205A1 (en) | 2008-02-11 | 2009-08-12 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | PSMB10: A diagnosis marker and therapeutic target of chronic rejection. |
| SI2318419T2 (sl) | 2008-06-17 | 2025-10-30 | Takeda Pharmaceutical Company Limited | Spojine boronat estra in njihovi farmacevtski sestavki |
| BRPI0916576A2 (pt) | 2008-08-04 | 2017-06-27 | Chdi Inc | pelo menos uma entidade química, composição farmacêutica, e, método para tratar uma condição ou distúrbio. |
| AR075090A1 (es) | 2008-09-29 | 2011-03-09 | Millennium Pharm Inc | Derivados de acido 1-amino-2-ciclobutiletilboronico inhibidores de proteosoma,utiles como agentes anticancerigenos, y composiciones farmaceuticas que los comprenden. |
| JP5675629B2 (ja) | 2008-10-21 | 2015-02-25 | オニキス セラピューティクス, インク.Onyx Therapeutics, Inc. | ペプチドエポキシケトンを用いた併用療法 |
| AR075899A1 (es) | 2009-03-20 | 2011-05-04 | Onyx Therapeutics Inc | Tripeptidos epoxicetonas cristalinos inhibidores de proteasa |
| EP2238973A1 (en) | 2009-04-07 | 2010-10-13 | Cephalon France | Lyophilized preparations of proteasome inhibitors |
| WO2011060179A1 (en) | 2009-11-13 | 2011-05-19 | Onyx Therapeutics, Inc | Use of peptide epoxyketones for metastasis suppression |
| NZ600786A (en) | 2009-12-22 | 2013-12-20 | Cephalon Inc | Proteasome inhibitors and processes for their preparation, purification and use |
| NZ601547A (en) | 2010-01-25 | 2014-04-30 | Chdi Foundation Inc | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| AU2011223795B2 (en) | 2010-03-01 | 2015-11-05 | Onyx Therapeutics, Inc. | Compounds for immunoproteasome inhibition |
| US9126997B1 (en) | 2010-09-07 | 2015-09-08 | Northwestern University | Synergistic effect of glucocorticoid receptor agonists in combination with proteosome inhibitors for treating leukemia and myeloma |
| ES2548256T3 (es) | 2010-10-14 | 2015-10-15 | Synthon Bv | Proceso para la preparación de bortezomib y los intermedios para el proceso |
| WO2013033068A1 (en) | 2011-08-30 | 2013-03-07 | Stephen Martin Courtney | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| SG2014012926A (en) | 2011-08-30 | 2014-06-27 | Chdi Foundation Inc | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| WO2014011695A2 (en) | 2012-07-09 | 2014-01-16 | Onyx Therapeutics, Inc. | Prodrugs of peptide epoxy ketone protease inhibitors |
| WO2014072985A1 (en) * | 2012-11-06 | 2014-05-15 | Natco Pharma Limited | Novel boronic acid derivatives as anti cancer agents |
| US9493439B1 (en) | 2014-04-07 | 2016-11-15 | University Of Kentucky Research Foundation | Proteasome inhibitors |
| ES2953522T3 (es) | 2014-04-08 | 2023-11-14 | Abliva Ab | Compuestos de succinato novedosos con permeabilidad celular |
| UA121389C2 (uk) | 2014-05-20 | 2020-05-25 | Мілленніум Фармасьютікалз, Інк. | Борвмісні інгібітори протеасом для застосування після первинної протиракової терапії |
| MX372995B (es) | 2014-07-17 | 2020-04-13 | Chdi Foundation Inc | Metodos y composiciones para el tratamiento de trastornos relacionados con vih. |
| MX379576B (es) * | 2017-02-28 | 2025-03-11 | Chia Tai Tianqing Pharmaceutical Group Co Ltd | Derivados de azetidina |
| GB201808149D0 (en) | 2018-05-18 | 2018-07-11 | Univ Court Univ Of Glasgow | Protected amino acids |
| US11466036B2 (en) | 2018-08-02 | 2022-10-11 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Borate of azetidine derivative |
| WO2026010901A1 (en) * | 2024-07-03 | 2026-01-08 | Merck Sharp & Dohme Llc | Process for preparing lipidated peptide and its intermediates |
Family Cites Families (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3301354A1 (de) | 1983-01-18 | 1984-07-19 | Matth. Hohner Ag, 7218 Trossingen | Elektronisches musikinstrument |
| US4499082A (en) * | 1983-12-05 | 1985-02-12 | E. I. Du Pont De Nemours And Company | α-Aminoboronic acid peptides |
| US4537773A (en) * | 1983-12-05 | 1985-08-27 | E. I. Du Pont De Nemours And Company | α-Aminoboronic acid derivatives |
| US5250720A (en) * | 1987-06-05 | 1993-10-05 | The Dupont Merck Pharmaceutical Company | Intermediates for preparing peptide boronic acid inhibitors of trypsin-like proteases |
| US5187157A (en) | 1987-06-05 | 1993-02-16 | Du Pont Merck Pharmaceutical Company | Peptide boronic acid inhibitors of trypsin-like proteases |
| US5242904A (en) * | 1987-06-05 | 1993-09-07 | The Dupont Merck Pharmaceutical Company | Peptide boronic acid inhibitors of trypsin-like proteases |
| EP0315574A3 (de) * | 1987-11-05 | 1990-08-22 | Hoechst Aktiengesellschaft | Renin-Inhibitoren |
| AU3418389A (en) | 1988-03-28 | 1989-10-16 | Regents Of The University Of California, The | Nerve growth factor peptides |
| US5023236A (en) * | 1988-04-07 | 1991-06-11 | Corvas, Inc. | Factor VII/VIIA active site inhibitors |
| US5159060A (en) * | 1988-05-27 | 1992-10-27 | Mayo Foundation For Medical Education And Research | Cytotoxic boronic acid peptide analogs |
| US5106948A (en) * | 1988-05-27 | 1992-04-21 | Mao Foundation For Medical Education And Research | Cytotoxic boronic acid peptide analogs |
| US4963655A (en) * | 1988-05-27 | 1990-10-16 | Mayo Foundation For Medical Education And Research | Boron analogs of amino acid/peptide protease inhibitors |
| DE3827340A1 (de) | 1988-08-12 | 1990-02-15 | Hoechst Ag | Verwendung von (alpha)-aminoboronsaeure-derivaten zur prophylaxe und behandlung von viruserkrankungen |
| HUT62312A (en) | 1990-03-05 | 1993-04-28 | Cephalon Inc | Process for producing chymotrypsin-like proteases and their inhibitors |
| EP0583536B1 (en) * | 1992-08-14 | 1997-03-05 | The Procter & Gamble Company | Liquid detergents containing an alpha-amino boronic acid |
| AU676721B2 (en) | 1993-02-10 | 1997-03-20 | Dana-Farber Cancer Institute | Role of ATP-ubiquitin-dependent proteolysis in MHC-1 restricted antigen presentation and inhibitors thereof |
| IL109319A0 (en) | 1993-04-27 | 1994-07-31 | Du Pont Merck Pharma | Amidino and guanidino substituted boronic acid compounds |
| US5658885A (en) * | 1993-04-27 | 1997-08-19 | The Dupont Merck Pharmaceutical Company | Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes |
| EP0699074B1 (en) | 1993-04-30 | 2002-11-13 | Merck & Co. Inc. | Thrombin inhibitors |
| US5672582A (en) | 1993-04-30 | 1997-09-30 | Merck & Co., Inc. | Thrombin inhibitors |
| FR2707085B1 (fr) * | 1993-06-30 | 1995-08-18 | Adir | Nouveaux dérivés d'alpha amino acides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
| ES2170104T3 (es) | 1993-10-01 | 2002-08-01 | Merrell Pharma Inc | Inhibidores de la produccion de proteinas de beta-amiloide. |
| IL111175A0 (en) | 1993-10-07 | 1994-12-29 | Du Pont Merck Pharma | Electrophilic peptide analogs as inhibitors of trypsin-like serine proteases and pharmaceutical compositions containing them |
| GB9401483D0 (en) | 1994-01-26 | 1994-03-23 | Sandoz Ltd | Organic compounds |
| US5693617A (en) * | 1994-03-15 | 1997-12-02 | Proscript, Inc. | Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein |
| US6660268B1 (en) | 1994-03-18 | 2003-12-09 | The President And Fellows Of Harvard College | Proteasome regulation of NF-KB activity |
| US6083903A (en) * | 1994-10-28 | 2000-07-04 | Leukosite, Inc. | Boronic ester and acid compounds, synthesis and uses |
| US5614649A (en) | 1994-11-14 | 1997-03-25 | Cephalon, Inc. | Multicatalytic protease inhibitors |
| US5550262A (en) * | 1994-11-14 | 1996-08-27 | Cephalon, Inc. | Multicatalytic protease inhibitors |
| US5834487A (en) * | 1996-09-24 | 1998-11-10 | Cv Therapeutics | Inhibition of 26S and 20S proteasome by indanones |
| NZ335276A (en) | 1996-10-18 | 2000-09-29 | Vertex Pharma | Inhibitors of serine proteases, particularly hepatitis C virus (HCV) NS3 (Non Structural Protein 3) protease |
| GB9623908D0 (en) | 1996-11-18 | 1997-01-08 | Hoffmann La Roche | Amino acid derivatives |
| US6096778A (en) * | 1997-10-07 | 2000-08-01 | Cephalon, Inc. | α-ketoamide multicatalytic protease inhibitors |
| CA2314259A1 (en) * | 1997-12-16 | 1999-06-24 | Robert Siman | Multicatalytic protease inhibitors for use as anti-tumor agents |
| US6075150A (en) * | 1998-01-26 | 2000-06-13 | Cv Therapeutics, Inc. | α-ketoamide inhibitors of 20S proteasome |
| GB9806815D0 (en) * | 1998-03-30 | 1998-05-27 | Hoffmann La Roche | Amino acid derivatives |
| US6462019B1 (en) | 1998-07-10 | 2002-10-08 | Osteoscreen, Inc. | Inhibitors of proteasomal activity and production for stimulating bone growth |
| EP0995757A3 (en) | 1998-08-26 | 2002-05-22 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Bivalent inhibitors of the proteasome |
| AU762373B2 (en) | 1998-10-20 | 2003-06-26 | Millennium Pharmaceuticals, Inc. | Method for monitoring proteasome inhibitor drug action |
| EP1053750A1 (en) | 1999-04-22 | 2000-11-22 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Use of proteasome-inhibitor for the induction of programmed cell death (apoptosis) |
| ATE270268T1 (de) | 1999-04-27 | 2004-07-15 | Novartis Pharma Gmbh | 2,4-diamino-3-hydroxycarboxylsäurederivate als proteasome inhibitoren |
| SE9901573D0 (sv) | 1999-05-03 | 1999-05-03 | Astra Ab | New compounds |
| WO2001002424A2 (en) | 1999-07-07 | 2001-01-11 | Du Pont Pharmaceuticals Company | Peptide boronic acid inhibitors of hepatitis c virus protease |
| US7122627B2 (en) | 1999-07-26 | 2006-10-17 | Bristol-Myers Squibb Company | Lactam inhibitors of Hepatitis C virus NS3 protease |
| AU7832000A (en) | 1999-09-23 | 2001-04-24 | Washington University | Compounds directed against pilus biogenesis and activity in pathogenic bacteria;methods and compositions for synthesis thereof |
| JP2003528039A (ja) | 1999-10-20 | 2003-09-24 | オステオスクリーン,インコーポレイテッド | 骨および毛成長を刺激するためのプロテアソーム活性のインヒビター |
| SK742003A3 (en) | 2000-07-21 | 2003-06-03 | Schering Corp | Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
| ES2272558T3 (es) | 2000-10-12 | 2007-05-01 | Viromics Gmbh | Inhibidores del proteasoma para el tratamiento de infecciones causadas por virus de la hepatitis. |
| CA2435146C (en) | 2001-01-25 | 2011-03-29 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Formulation of boronic acid compounds |
| CA2443813A1 (en) | 2001-04-09 | 2002-10-17 | Allan Christian Shaw | Method for identification of proteins from intracellular bacteria |
| US7214769B2 (en) | 2001-05-23 | 2007-05-08 | The Curators Of The University Of Missouri | Method for inverse solid phase synthesis of peptides |
| EP1399468B1 (en) | 2001-05-30 | 2006-02-15 | Novartis AG | 2-((n-(2-amino-3-(heteroaryl or aryl)propionyl)-aminoacyl)-amino)-alkylboronic acid derivatives |
| KR100399359B1 (ko) * | 2001-07-07 | 2003-09-26 | 삼성전자주식회사 | 전하 펌프 회로 |
| AU2002324734A1 (en) | 2001-08-16 | 2003-03-03 | Levente Fabry-Asztalos | Borinic acid protease inhibitors |
| WO2003033507A1 (en) | 2001-10-12 | 2003-04-24 | Kyorin Pharmaceutical Co., Ltd. | Benzylmalonic acid derivatives and proteasome inhibitors contaiing the same |
| EP1463719A2 (en) * | 2002-01-08 | 2004-10-06 | Eisai Co., Ltd | Eponemycin and epoxomicin analogs and uses thereof |
| WO2005016659A1 (ja) | 2003-08-13 | 2005-02-24 | Seiko Precision Inc. | カードの製造方法及びカード製造装置 |
| US7576206B2 (en) * | 2003-08-14 | 2009-08-18 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
| KR20140042933A (ko) | 2007-08-06 | 2014-04-07 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | 프로테아좀 억제제 |
-
2006
- 2006-02-09 US US11/351,193 patent/US7468383B2/en not_active Expired - Fee Related
- 2006-02-10 MY MYPI20060567A patent/MY147921A/en unknown
- 2006-02-10 PT PT06734698T patent/PT1846424E/pt unknown
- 2006-02-10 EP EP06734698A patent/EP1846424B1/en not_active Expired - Lifetime
- 2006-02-10 CA CA2597273A patent/CA2597273C/en not_active Expired - Fee Related
- 2006-02-10 TW TW095104473A patent/TWI367886B/zh not_active IP Right Cessation
- 2006-02-10 NZ NZ560607A patent/NZ560607A/en not_active IP Right Cessation
- 2006-02-10 PL PL06734698T patent/PL1846424T3/pl unknown
- 2006-02-10 AT AT06734698T patent/ATE456571T1/de active
- 2006-02-10 WO PCT/US2006/004664 patent/WO2006086600A1/en not_active Ceased
- 2006-02-10 DK DK06734698.1T patent/DK1846424T3/da active
- 2006-02-10 MX MX2007009664A patent/MX2007009664A/es active IP Right Grant
- 2006-02-10 ES ES06734698T patent/ES2339698T3/es not_active Expired - Lifetime
- 2006-02-10 AU AU2006213814A patent/AU2006213814B2/en not_active Ceased
- 2006-02-10 DE DE602006012013T patent/DE602006012013D1/de not_active Expired - Lifetime
- 2006-02-10 JP JP2007555228A patent/JP2008530108A/ja active Pending
- 2006-02-10 SI SI200630615T patent/SI1846424T1/sl unknown
-
2007
- 2007-07-17 IL IL184678A patent/IL184678A/en not_active IP Right Cessation
-
2008
- 2008-11-06 US US12/265,998 patent/US8283367B2/en not_active Expired - Fee Related
-
2010
- 2010-04-27 CY CY20101100375T patent/CY1109985T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG158119A1 (en) | Anti-integrin immunoconjugates, methods and uses | |
| JP2006504723A5 (cg-RX-API-DMAC7.html) | ||
| JP2008502584A5 (cg-RX-API-DMAC7.html) | ||
| JP2005511597A5 (cg-RX-API-DMAC7.html) | ||
| JP2009102444A5 (ja) | 二次性骨腫瘍の治療のための抗PDGFRα抗体 | |
| JP2008526765A5 (cg-RX-API-DMAC7.html) | ||
| RU2013151904A (ru) | Применение соединений мышьяка для лечения отторжения ткани или органа | |
| JP2009530288A5 (cg-RX-API-DMAC7.html) | ||
| JP2016536361A5 (cg-RX-API-DMAC7.html) | ||
| WO2009043522A3 (en) | Use of a peptide as a therapeutic agent | |
| WO2007113558A3 (en) | Quinazolinone derivatives having b-raf inhibitory activity | |
| JP2003503454A5 (cg-RX-API-DMAC7.html) | ||
| ATE497770T1 (de) | Pharmazeutische formulierungen von decitabin | |
| DK2305255T3 (da) | Arylurinstofforbindelser i kombination med andre cytostatiske eller cytotoksiske midler til behandling af humane cancere | |
| WO2007117467A3 (en) | Use of tm-601 for the diagnosis and treatment of tumors | |
| WO2007071963A3 (en) | Quinazoline derivatives, process for their preparation and their use as anti-cancer agents | |
| ATE448232T1 (de) | Substituierte heterozyklen | |
| JP2016128507A5 (cg-RX-API-DMAC7.html) | ||
| JP2007518815A5 (cg-RX-API-DMAC7.html) | ||
| TNSN07294A1 (en) | Treatment of metastasized tumors | |
| EA200700686A1 (ru) | Липосомы, включающие радиоактивный изотоп, и цитотоксический агент для комбинированной терапии | |
| JP2015507020A5 (cg-RX-API-DMAC7.html) | ||
| JP2010500284A5 (cg-RX-API-DMAC7.html) | ||
| JP2012527424A5 (cg-RX-API-DMAC7.html) | ||
| JP2005530735A5 (cg-RX-API-DMAC7.html) |